AAV9 gene transfer of cMyBPC N-terminal domains ameliorates cardiomyopathy in cMyBPC-deficient mice

Decreased cardiac myosin-binding protein C (cMyBPC) expression due to inheritable mutations is thought to contribute to the hypertrophic cardiomyopathy (HCM) phenotype, suggesting that increasing cMyBPC content is of therapeutic benefit. In vitro assays show that cMyBPC N-terminal domains (NTDs) con...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiayang, Mamidi, Ranganath, Doh, Chang Yoon, Holmes, Joshua B., Bharambe, Nikhil, Ramachandran, Rajesh, Stelzer, Julian E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526450/
https://www.ncbi.nlm.nih.gov/pubmed/32750038
http://dx.doi.org/10.1172/jci.insight.130182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526450/
https://www.ncbi.nlm.nih.gov/pubmed/32750038
http://dx.doi.org/10.1172/jci.insight.130182

Ejemplares similares